account_num,net_change,tag,tag_depth,cik
2091,103770000.0,AssetsNoncurrent,2,921299_FIBROGEN INC
455,41179000.0,InventoryNet,2,921299_FIBROGEN INC
260,41179000.0,InventoryNetOfAllowancesCustomerAdvancesAndProgressBillings,4,921299_FIBROGEN INC
868,411357000.0,AssetsCurrent,2,921299_FIBROGEN INC
1634,74404000.0,OperatingLeaseRightOfUseAsset,2,921299_FIBROGEN INC
1368,16829000.0,PropertyPlantAndEquipmentNet,4,921299_FIBROGEN INC
3750,-1625067000.0,AdditionalPaidInCapital,1,921299_FIBROGEN INC
320,25599000.0,ReceivablesNetCurrent,3,921299_FIBROGEN INC
2089,515127000.0,Assets,1,921299_FIBROGEN INC
3465,-575434000.0,Liabilities,1,921299_FIBROGEN INC
2347,-12802000.0,AccountsPayableAndAccruedLiabilitiesCurrent,3,921299_FIBROGEN INC
3154,-194072000.0,LiabilitiesCurrent,2,921299_FIBROGEN INC
3308,-71408000.0,LongTermDebtNoncurrent,2,921299_FIBROGEN INC
3303,-71408000.0,LongTermDebtAndCapitalLeaseObligations,2,921299_FIBROGEN INC
3379,-73813000.0,OperatingLeaseLiabilityNoncurrent,3,921299_FIBROGEN INC
3796,-244190000.0,LiabilitiesOtherThanLongtermDebtNoncurrent,3,921299_FIBROGEN INC
3645,-315598000.0,LiabilitiesNoncurrent,2,921299_FIBROGEN INC
3661,-982000.0,CommonStockValue,3,921299_FIBROGEN INC
207,25599000.0,AccountsNotesAndLoansReceivableNetCurrent,4,921299_FIBROGEN INC
2398,-12802000.0,AccountsPayableCurrent,2,921299_FIBROGEN INC
229,25599000.0,AccountsReceivableNetCurrent,3,921299_FIBROGEN INC
645,152585000.0,CashAndCashEquivalentsAtCarryingValue,3,921299_FIBROGEN INC
3834,-1722073000.0,RetainedEarningsAccumulatedDeficit,1,921299_FIBROGEN INC
577,335716000.0,CashCashEquivalentsAndShortTermInvestments,4,921299_FIBROGEN INC
3316,-102274000.0,StockholdersEquity,1,921299_FIBROGEN INC
3917,-515127000.0,LiabilitiesAndStockholdersEquity,2,921299_FIBROGEN INC
3260,-81787000.0,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,2,921299_FIBROGEN INC
232,-9199000.0,GrossProfit,1,921299_FIBROGEN INC
601,65455000.0,SellingGeneralAndAdministrativeExpense,3,921299_FIBROGEN INC
961,-1000.0,GainLossOnSaleOfPropertyPlantEquipment,1,921299_FIBROGEN INC
1002,-1000.0,GainLossOnDispositionOfAssets1,1,921299_FIBROGEN INC
1112,236077000.0,OperatingExpenses,1,921299_FIBROGEN INC
1264,-164138000.0,OperatingIncomeLoss,1,921299_FIBROGEN INC
2041,4353000.0,OtherAssetsNoncurrent,2,921299_FIBROGEN INC
3333,-21480000.0,TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests,3,921299_FIBROGEN INC
3400,-21480000.0,RedeemableNoncontrollingInterestEquityCarryingAmount,3,921299_FIBROGEN INC
2764,-7490000.0,ContractWithCustomerLiabilityCurrent,3,921299_FIBROGEN INC
3279,-165416000.0,DeferredRevenueNoncurrent,2,921299_FIBROGEN INC
3339,-165416000.0,ContractWithCustomerLiabilityNoncurrent,3,921299_FIBROGEN INC
990,-1000.0,GainLossOnDispositionOfAssets,4,921299_FIBROGEN INC
2710,-7490000.0,DeferredRevenueCurrent,2,921299_FIBROGEN INC
3853,-20487000.0,MinorityInterest,1,921299_FIBROGEN INC
2603,-80480000.0,NoninterestIncome,1,921299_FIBROGEN INC
110,-80480000.0,RevenueFromContractWithCustomerExcludingAssessedTax,2,921299_FIBROGEN INC
1478,-1346000.0,IncomeLossFromEquityMethodInvestments,1,921299_FIBROGEN INC
2306,2072000.0,RestrictedCashAndCashEquivalentsNoncurrent,3,921299_FIBROGEN INC
581,170621000.0,OperatingCostsAndExpenses,2,921299_FIBROGEN INC
491,169964000.0,ResearchAndDevelopmentExpense,2,921299_FIBROGEN INC
144,9199000.0,CostOfRevenue,1,921299_FIBROGEN INC
3809,-6250000.0,AccumulatedOtherComprehensiveIncomeLossNetOfTax,2,921299_FIBROGEN INC
3494,-4961000.0,OtherLiabilitiesNoncurrent,2,921299_FIBROGEN INC
1848,6112000.0,LongTermInvestmentsAndReceivablesNet,3,921299_FIBROGEN INC
1626,6112000.0,LongTermInvestments,1,921299_FIBROGEN INC
1557,6112000.0,InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures,6,921299_FIBROGEN INC
1494,6112000.0,EquityMethodInvestments,1,921299_FIBROGEN INC
281,183131000.0,ShortTermInvestments,1,921299_FIBROGEN INC
2903,-87680000.0,NetIncomeLossAvailableToCommonStockholdersDiluted,2,921299_FIBROGEN INC
2590,-87680000.0,NetIncomeLossAvailableToCommonStockholdersBasic,2,921299_FIBROGEN INC
456,657000.0,DepreciationAndAmortization,4,921299_FIBROGEN INC
1912,-87680000.0,NetIncomeLoss,1,921299_FIBROGEN INC
1864,2072000.0,RestrictedCashAndInvestmentsNoncurrent,3,921299_FIBROGEN INC
3281,-71408000.0,SecuredLongTermDebt,2,921299_FIBROGEN INC
565,657000.0,FinanceLeaseRightOfUseAssetAmortization,3,921299_FIBROGEN INC
3824,-20487000.0,NonredeemableNoncontrollingInterest,1,921299_FIBROGEN INC
1077,-164385000.0,ProfitLoss,2,921299_FIBROGEN INC
845,657000.0,AmortizationOfDeferredCharges,1,921299_FIBROGEN INC
2399,161000.0,IncomeTaxExpenseBenefit,1,921299_FIBROGEN INC
1820,-167399000.0,IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest,3,921299_FIBROGEN INC
1854,5441000.0,InterestAndDebtExpense,2,921299_FIBROGEN INC
2149,-165892000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments,3,921299_FIBROGEN INC
1709,5441000.0,InterestExpense,1,921299_FIBROGEN INC
2130,-3687000.0,NonoperatingIncomeExpense,1,921299_FIBROGEN INC
2257,-167238000.0,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,2,921299_FIBROGEN INC
